![Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/17/20/6459/F1.large.jpg)
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
![Localization and expression of polo-like kinase (PLK)4 during meiotic... | Download Scientific Diagram Localization and expression of polo-like kinase (PLK)4 during meiotic... | Download Scientific Diagram](https://www.researchgate.net/profile/Yi_Bo_Luo/publication/273149297/figure/fig2/AS:667717828886530@1536207744103/Localization-and-expression-of-polo-like-kinase-PLK4-during-meiotic-maturation-of-mouse.png)
Localization and expression of polo-like kinase (PLK)4 during meiotic... | Download Scientific Diagram
![PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability](https://i1.rgstatic.net/publication/41139223_Polo-like_kinase_4_activity_limits_centrosome_overduplication_by_autoregulating_its_own_stability/links/0fcfd507eeddfb81aa000000/largepreview.png)
PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability
![Molecules | Free Full-Text | Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors Molecules | Free Full-Text | Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors](https://www.mdpi.com/molecules/molecules-24-01488/article_deploy/html/images/molecules-24-01488-ag.png)
Molecules | Free Full-Text | Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
![Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrm3819/MediaObjects/41580_2014_Article_BFnrm3819_Fig1_HTML.jpg)
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
![Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/17/20/6459/F2.large.jpg)
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
![APExBIO - CFI-400945 orally available, selective inhibitor of polo-like kinase 4 (PLK4) | CAS# 1338800-06-8 APExBIO - CFI-400945 orally available, selective inhibitor of polo-like kinase 4 (PLK4) | CAS# 1338800-06-8](https://www.apexbt.com/media/diy/images/struct/C5813.png)